Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 14, 2019
Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company") today announced that it will participate in two upcoming investor conferences: 8th Annual SVB Leerink Global Healthcare Conference on...
-
Jan 5, 2017-- $12 Million Series A financing supports development of best-in-class therapy for acute migraine that incorporates novel and proprietary SNBL nasal drug delivery technology --
Satsuma Pharmaceuticals, Inc., a leader in developing best-in-class therapies to address the unmet needs of migraine sufferers, today announced the closing of a $12 million Series A financing...